The full survey, released Tuesday, shows that 66 percent of anesthesiologists are seeing a shortage in fentanyl, followed by thiopental (40 percent), succinylcholine (20 percent), propofol (19 percent) and pancuronium (15 percent). Anesthesiologists also noted that as a result of these shortages, patients experienced post-operative nausea and vomiting (66 percent) and longer OR and recovery times (52 percent).
Initial survey data indicated that at least seven patient deaths had occurred as a result of the nationwide anesthesia drug shortage.
Related Articles on Anesthesia:
Anesthesiologist Studies Survival Rate of Helicopter Transport Patients
Florida Gulf-to-Bay Anesthesiology Associates Partners With Private Equity Firm
Medicare ACOs Are Blooming (With or Without Anesthesiologists)
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
